#United States #Boston #CAR-T therapy #RA Capital #NexCure

NexCure, Inc. Launches to Transform Advanced Treatment Access

NexCure, Inc. has officially launched with a mission to tackle one of the most significant issues in healthcare: the accessibility of advanced treatments like CAR-T therapy. This innovative company aims to facilitate the delivery of life-saving therapies directly in community outpatient settings, thus ensuring that patients have easier access to critical care. The launch is bolstered by a notable $19 million Series A financing round, prominently led by RA Capital Management, with supportive investments from Cencora Ventures and Oncology Ventures.

The concept behind NexCure is to bring complex therapies closer to patients by integrating purpose-built outpatient clinics equipped with state-of-the-art technology that supports the demanding nature of services such as CAR-T and other advanced therapeutics. By expanding outpatient services for these treatments, NexCure aims to eliminate the geographical and financial barriers that have long hindered patient access to essential healthcare services.

A Vision for Change

In a statement regarding the launch, Sophie Papa, FRCP, PhD, the Founder and Chief Medical Officer of NexCure, expressed her commitment to overcoming operational hurdles that care providers face. She emphasized the transformative impact that therapies such as CAR-T can deliver, especially for patients grappling with severe illnesses like cancer. NexCure is determined to address existing gaps in access to these therapies, working tirelessly to reshape how advanced treatment is accessed by patients.

As reported, only about 3% of the approximately 6,100 hospitals in the U.S. are currently equipped to administer CAR-T therapy. This statistic underscores the extent of the challenge NexCure is tackling. "Today, only a fraction of patients eligible for CAR-T therapy receive it due to barriers in care delivery,” stated Paul Rothman, MD, a Venture Partner at Raven and Chief Founder of NexCure.

He added that as CAR-T therapy evolves and expands beyond oncology to treat autoimmune diseases and others, NexCure’s initiative is essential for developing reference points for delivery in safe and effective settings.

Revolutionizing Therapy Delivery

NexCure is not only creating physical spaces for advanced therapies but also developing a proprietary platform that standardizes operational protocols to streamline care coordination and reduce variability. This positioning allows advanced treatments to be made available beyond the limited number of academic medical centers. The funding raised is critical in the efforts to build out this infrastructure effectively, integrating essential components such as clinical decision support and real-time monitoring capabilities.

Ben Freeberg, Founder and Managing Partner of Oncology Ventures, expressed excitement about investing in NexCure, highlighting the company’s potential to address the infrastructural bottlenecks in therapy delivery through a scalable outpatient model. This innovative approach stands to improve patient access considerably while enhancing care efficiency.

Leadership Driving Change

The team helming NexCure consists of highly experienced professionals in the healthcare realm. Paul Rothman, MD serves as the founder and Board Chair, bringing a wealth of knowledge from his former roles in Johns Hopkins University and dedication to translating healthcare innovation into practice. Additionally, Jennifer Smith, as CEO, brings two decades of operational expertise focused on expanding healthcare access. Dr. Sophie Papa, alongside Anish More, who acts as the Chief Business Officer, collectively form a robust leadership team committed to scaling NexCure’s mission.

About NexCure

NexCure is designed to revolutionize the landscape of healthcare by providing clinically intensive therapeutics in community outpatient settings specifically tailored for advanced treatments like CAR-T. The organization leverages advanced technology, including AI-driven patient selection and remote monitoring, to ensure personalized and safe treatment for all patients. Through these innovations, NexCure aims to set a new standard in patient care.

For more in-depth information, NexCure invites readers to visit their website at nexcure.com.